Biotech companies developing new drugs are plagued by rumors that adversely affect investor sentiment.Faced with a series of speculations about the equity sale by the largest shareholders and plans for a capital increase, SCM Lifescience, ABL Bio, NKMAX, and Genome & Company have responded with offi
Marking Rare Disease Day on Feb. 29, the Korea Disease Control and Prevention Agency (KDCA) held its 8th Rare Disease Day commemorative event on Wednesday to enhance public awareness of rare diseases and to encourage the determination of rare disease patients and their families to overcome illnesses
Celltrion said Thursday that it has completed submitting a marketing authorization application for CT-P47, a biosimilar to Actemra (tocilizumab) for treating autoimmune diseases, to the Ministry of Food and Drug Safety (MFDS).Celltrion has applied for the marketing authorization of CT-P47 for the fu
Severance Hospital said that Professor Kuh Sung-uk at the Department of Neurosurgery, who also teaches at Yonsei University's College of Medicine, was honored with the grand prize at the 8th Medical Device Industry Awards Ceremony.Professor Kuh also serves as head of external relations at Severance
Korea’s state health insurance system recorded a surplus for three years in a row, with accumulated reserves reaching a record 28 trillion won ($21 billion).Both income and expense increased year-on-year, but income grew more significantly. After Covid-19, hospital-level medical institutions recover
Celltrion said it has commenced the first shipment of Zymfentra, the world’s first subcutaneous form of infliximab, to the U.S. targeting autoimmune diseases. The company announced that the initial shipment batch was airlifted today to Atlanta, U.S., with plans to complete three shipment phases by e
Dentis said Wednesday that it has obtained approval from the U.S. Food and Drug Administration (FDA) for its sheet used for clear orthodontic device, “Serafin.”“MESHEET,” developed by Dentis, is a dental orthodontic sheet with a composite structure embedded with a mesh-structured cushioning mat, and
PARP (poly ADP-ribose polymerase) inhibitors have recently emerged as a new treatment option for metastatic castration-resistant prostate cancer (mCRPC) with a poor prognosis and are expected to contribute significantly to improving survival rates.However, they remain far beyond the reach of most Ko
The government plans to implement the use of "e-labels" for certain biopharmaceutical products, including the newly developed antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) and the anti-PD-1 immunotherapy Keytruda (pembrolizumab).Last Friday, the Ministry of Food and Drug Safety anno
The last day of February every year is “World Rare Disease Day.” People who decided it reportedly thought about the rarity of February, the last day of which ends on the 29th every four years, to symbolize the experiences of people with rare diseases. Korea had celebrated it on May 24 until last yea
A Korean research team, led by Professor Kim Na-young at the Department of Internal Medicine of Seoul National University Bundang Hospital (SNUBH), analyzed the differences between males and females with stomach cancer positive for the Epstein-Barr virus (EBV), which infects more than 90 percent of
In the rapidly evolving landscape of healthcare, digital therapeutics (DTx) have emerged as a groundbreaking third generation of treatment, drawing global attention as a promising sector. These software-based interventions, designed to treat diseases and enhance health much like traditional pharmace
Kakao Healthcare said over 50 health regulatory officials, including those from the Ministry of Food and Drug Safety, the WHO, and the U.S. FDA, visited its headquarters on Monday in light of the AI Regulatory and International Symposium 2024 (AIRIS 2024).The event is ongoing at the Shilla Seoul Hot
CHA Biotech has launched a study to enhance the anticancer efficacy of its natural killer (NK) cell therapeutic drug by making the most of polymer, a cationic compound.The cationic compounds used in the study are synthetic polymers, in which monomers, molecules with low molecular weight, are repeate
The government has released a draft of the “Special Act on Handling of Medical Accidents" to appease the medical community, which has been protesting against the increase in medical school students.However, it remains to be seen whether the proposed law will be enacted, as the timeline for its imple
A Severance Hospital research team has revealed that a hemostatic powder made from plant extracts significantly improves the success rate of initial hemostasis in patients with gastrointestinal bleeding caused by peptic ulcers.Peptic ulcers, which result from the digestive acid eroding the lining of
Professor Keum Ki-chang of radiation oncology at Yonsei University College of Medicine has been appointed as CEO and President of Yonsei University Health System (YUHS) and YUHS Vice President for Health Sciences, Severance Hospital said on Tuesday. His term will begin on March 1 and will last for f
The government has concluded that the recent death of a cardiac arrest patient in her 80s in Daejeon while being transported by ambulance was not related to "emergency rooms’ refusal to accept patients.”The Ministry of Health and Welfare said Tuesday that it reached such a conclusion after conductin
BeiGene, a global biotech firm founded in 2010 in Beijing, is strengthening its global presence by expanding its workforce and boosting sales.The company is waiting for the U.S. Food and Drug Administration (FDA) to approve its anti-PD-1 immuno-oncology drug Tevimbra (tislelizumab) this year, drawin
Starting next month, biliary tract cancer patients can add the anti-PD-L1 immunotherapy Imfinzi (durvalumab) at their own expense to the existing gemcitabine/cisplatin (GemCis) chemotherapy regimen for the first-line treatment of locally progressive or metastatic biliary tract cancer.It was part of